Gene · 5803
Papers1,425
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,425
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PTPRZ1 dephosphorylates and stabilizes RNF26 to reduce the efficacy of TKIs and PD-1 blockade in ccRCC. | Oncogene | 2024 | 39443724 | PubTator, text mining | PubMed |
| Case report: Germline CHEK2 mutation is associated with a giant cell glioblastoma. | Front Oncol | 2024 | 39411129 | PubTator, text mining | PubMed |
| Pleiotrophin Activates cMet- and mTORC1-Dependent Protein Synthesis through PTPRZ1-The Role of ανβ3 Integrin. | Int J Mol Sci | 2024 | 39409168 | PubTator, text mining | PubMed |
| PTPRZ1-Targeting RNA CAR T Cells Exert Antigen-Specific and Bystander Antitumor Activity in Glioblastoma. | Cancer Immunol Res | 2024 | 39269445 | PubTator, text mining | PubMed |
| Olanzapine Modulate Lipid Metabolism and Adipose Tissue Accumulation via Hepatic Muscarinic M3 Receptor-Mediated Alk-Related Signaling. | Biomedicines | 2024 | 39061977 | PubTator, text mining | PubMed |
| IL-34 and its receptors as predictors of brain metastasis and prognosis in lung adenocarcinoma: Unveiling insights through bioinformatic and immunohistochemical investigations. | Heliyon | 2024 | 39055827 | PubTator, text mining | PubMed |
| Novel RPTPγ and RPTPζ splice variants from mixed neuron-astrocyte hippocampal cultures as well as from the hippocampi of newborn and adult mice. | Front Physiol | 2024 | 38952869 | PubTator, text mining | PubMed |
| Novel genetic alterations in liver cancer distinguish distinct clinical outcomes and combination immunotherapy responses. | Front Pharmacol | 2024 | 38948469 | PubTator, text mining | PubMed |
| Data-independent acquisition combined with liquid chromatography mass spectrometry technique to detect prognostic protein markers in type I gastric neuroendocrine neoplasm. | Rapid Commun Mass Spectrom | 2024 | 38887896 | PubTator, text mining | PubMed |
| Step by step analysis on gene datasets of growth phases in hematopoietic stem cells. | Biochem Biophys Rep | 2024 | 38881758 | PubTator, text mining | PubMed |
| Evidence of mutant huntingtin and tau-related pathology within neuronal grafts in Huntington's disease cases. | Neurobiol Dis | 2024 | 38810948 | PubTator, text mining | PubMed |
| The PTPRZ1-MET/STAT3/ISG20 axis in glioma stem-like cells modulates tumor-associated macrophage polarization. | Cell Signal | 2024 | 38685521 | PubTator, text mining | PubMed |
| Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma. | Sci Rep | 2024 | 38493204 | PubTator, text mining | PubMed |
| Gene-gene interaction network analysis indicates CNTN2 is a candidate gene for idiopathic generalized epilepsy. | Neurogenetics | 2024 | 38460076 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing of anaplastic ependymoma and H3K27M-mutant diffuse midline glioma. | BMC Neurol | 2024 | 38383423 | PubTator, text mining | PubMed |
| Statement of Retraction: Protein tyrosine phosphatase receptor type Z1 inhibits the cisplatin resistance of ovarian cancer by regulating PI3K/AKT/mTOR signal pathway. | Bioengineered | 2024 | 38376410 | PubTator, text mining | PubMed |
| Keratan sulfate, an electrosensory neurosentient bioresponsive cell instructive glycosaminoglycan. | Glycobiology | 2024 | 38376199 | PubTator, text mining | PubMed |
| Clear-cell papillary renal cell tumour: New insights into clinicopathological features and molecular landscape after renaming by 5th WHO classification. | Pathol Res Pract | 2024 | 38324963 | PubTator, text mining | PubMed |
| Single-nucleus transcriptomic analysis reveals the relationship between gene expression in oligodendrocyte lineage and major depressive disorder. | J Transl Med | 2024 | 38281050 | PubTator, text mining | PubMed |
| Translation into Clinical Practice of the G1-G7 Molecular Subgroup Classification of Glioblastoma: Comprehensive Demographic and Molecular Pathway Profiling. | Cancers (Basel) | 2024 | 38254850 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5803/papers?page=4